Lloyd Advisory Services’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.6K Buy
+24
New +$13.5K ﹤0.01% 355
2026
Q1
Sell
-71
Closed -$48K 945
2025
Q4
$48K Buy
+71
New +$48.4K 0.02% 239
2022
Q2
Sell
-367
Closed -$201K 287
2022
Q1
$201K Buy
367
+31
+9% +$16.3K 0.09% 91
2021
Q4
$221K Buy
336
+65
+24% +$40.8K 0.1% 75
2021
Q3
$169K Buy
271
+55
+25% +$37K 0.09% 90
2021
Q2
$136K Buy
216
+67
+45% +$37K 0.07% 98
2021
Q1
$73K Buy
149
+127
+577% +$63.6K 0.04% 116
2020
Q4
$11K Hold
22
0.01% 197
2020
Q3
$9K Buy
+22
New +$8.13K 0.01% 191
2020
Q1
Sell
-8
Closed -$2K 330
2019
Q4
$2K Buy
+8
New +$2.11K ﹤0.01% 304

Other funds holding IDXX

Lloyd Advisory Services's IDXX Position: Q2 2026 in Review

Lloyd Advisory Services opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 24 shares worth $12.6K. The stake represents ﹤0.01% of the portfolio and ranks #355 among its holdings. This is a return to the name: Lloyd Advisory Services previously reported a position in IDXX as recently as Q4 2025.

Lloyd Advisory Services first reported a position in IDXX in Q4 2019 and has held it in 10 quarters since. The position peaked at $221K in Q4 2021. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Lloyd Advisory Services held 24 shares of Idexx Laboratories worth $12.6K as of Q2 2026.
  • Idexx Laboratories was a new Lloyd Advisory Services position in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Lloyd Advisory Services's portfolio in Q2 2026, its #355 holding.
  • Lloyd Advisory Services first reported a position in Idexx Laboratories in Q4 2019 and has held it in 10 quarters since.
  • Lloyd Advisory Services's Idexx Laboratories position peaked at $221K in Q4 2021.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Lloyd Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.